CHRS icon

Coherus Oncology, Inc. Common Stock
CHRS

Overview Fund Activity

135 hedge funds and large institutions have $143M invested in Coherus Oncology, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 36 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
-2
Holders Change %
-1.46%
% of All Funds
1.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
47
Reduced
36
Closed
24
Calls
$219K
Puts
$321K
Net Calls
-$102K
Net Calls Change
-$84K

Top Buyers

1
TCM
1
Tang Capital Management
California
$1.82M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$1.73M
3
AQR Capital Management
3
AQR Capital Management
Connecticut
$1.25M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$18.3M
5
BlackRock
5
BlackRock
New York
$20.3M

Top Sellers

1
Bank of America
1
Bank of America
North Carolina
$476K
2
Temasek Holdings
2
Temasek Holdings
Singapore
$10.1M
3
Morgan Stanley
3
Morgan Stanley
New York
$2.69M
4
Millennium Management
4
Millennium Management
New York
$1.07M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$1.44M
Name Holding Trade Value Shares
Change 		Shares
Change %
TC
151
Torno Capital
Massachusetts
– -$23.9K -10,000 Closed
PAS
152
Point72 Asia (Singapore)
Singapore
– -$8.14K -3,408 Closed
MLICM
153
Metropolitan Life Insurance Company (MetLife)
New York
– -$5.65K -2,365 Closed
PD
154
Point72 (DIFC)
United Arab Emirates
– -$2.55K -1,066 Closed
NA
155
NewEdge Advisors
Louisiana
– -$717 -300 Closed
FFA
156
Farther Finance Advisors
California
– -$218 -91 Closed
AWM
157
Avior Wealth Management
Nebraska
– -$74 -31 Closed
EBA
158
Eagle Bay Advisors
New York
– -$72 -30 Closed
3 4 5 6
7